2026 |
2026
Hershman DL, Till C, LeBlanc M, Ramsey S, Unger JM. Development and validation of a risk prediction model for acute care use among older advanced cancer patients on clinical trials. J Natl Cancer Inst. 2026 May 1;118(5):822-829. doi: 10.1093/jnci/djaf342. PMID: 41346251.
Ahluwalia MS, Solomon S, Patel SP, Sarfraz Z, Othus M, Chae YK, Kurzrock R. Efficacy and CNS Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multicenter Basket Trial Analysis (NCI/SWOG S1609). Clin Cancer Res. 2026 May 15;32(10):1928-1933. doi: 10.1158/1078-0432.CCR-25-2900. PMID: 41378983; PMCID: PMC13176817.
Masurekar AN, Burkett KM, Rahgozar A, Walter RB, Othus M, et al. Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence From Machine Learning and Regression Models. Transplant Cell Ther. 2026 May;32(5):575.e1-575.e12. doi: 10.1016/j.jtct.2025.12.996. Epub 2025 Dec 31. PMID: 41482160.
Olivieri D, Othus M, Vo P, Walter RB, Manjappa S, Basom R, Storb R, Keel S. Allogeneic hematopoietic cell transplantation for aplastic anemia: a single institution experience across 6 decades. Blood Adv. 2026 Apr 28;10(8):2661-2675. doi: 10.1182/bloodadvances.2025018548. PMID: 41637641; PMCID: PMC13100272.
Ayalew M, Hoffman AM, Fuller K, Kerr J, Lee A, Lee J, Martinez ES, Ulbricht K, Xie X. Microbiome education at under-resourced institutions: current status, barriers, and approaches to successful implementation. J Microbiol Biol Educ. 2026 Apr 17:e0028825. doi: 10.1128/jmbe.00288-25. Epub ahead of print. PMID: 41995339.
Chae YK, Othus M, Lyu J, Lee S, Paik S, Dietrich E, Jung CM, Chung LI, Patel S, Kurzrock R. Evaluation of mixed response in tumor size and survival in patients with rare cancers treated with dual checkpoint inhibitor therapy (DART SWOG S1609). J Immunother Cancer. 2026 Mar 11;14(3):e013260. doi: 10.1136/jitc-2025-013260. PMID: 41819545; PMCID: PMC12983688.
Turcsanyi L, Zhang XS, Kudelka M, Kubikova K, Radvansky M, Yang S, Kriegova E, Juranova J, Mayer J, Klamova H, Belohlavkova P, Karas M, Stejskal L, Cmunt E, Othus M, Gale RP, Jiang Q, Faber E. Chronic myeloid leukaemia: have basophils gone the way of the Dodo bird? Leukemia. 2026 Apr;40(4):713-716. doi: 10.1038/s41375-026-02910-9. Epub 2026 Mar 16. PMID: 41840226; PMCID: PMC13056533.
Swiecicki PL, Othus M, Patel SP, Kwang-Chae Y, Kurzrock R. Baseline tumor burden and outcomes in patients with rare cancers treated with immunotherapy (Southwest Oncology Group trial S1609). Cancer. 2026 Apr 1;132(7):e70374. doi: 10.1002/cncr.70374. PMID: 41892875; PMCID: PMC13025072.
Trivedi MS, Unger JM, Henry NL, Darke AK, Hertz DL, Brannagan TH, Reyes SJ, Schneider BP, Irvin WJ Jr, Hathaway AR, Vander Woude AC, Gudena VK, Cabrera-Galeana P, Orsted M, LeBlanc M, Fisch MJ, Hershman DL. Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage Cancer. JAMA Netw Open. 2026 Apr 1;9(4):e264901. doi: 10.1001/jamanetworkopen.2026.4901. PMID: 41961500; PMCID: PMC13069458.
Gupta A, Till C, LeBlanc ML, Hershman DL, Unger JM. Composition of Health Care Contact Days and Mortality Prediction Among Older Adult Clinical Trial Participants. JCO Oncol Pract. 2026 Apr 1:OP2501182. doi: 10.1200/OP-25-01182. Epub ahead of print. PMID: 41921118.
Chae YK, Czeskleba J, Patel SP, Mentor A, Robinson W, Jones NL, Rampurwala M, Naing A, Beck JM, Moloney-Lineen C, Chung LI, McLeod CM, Chen HX, Sharon E, Threlkel S, Othus M, Ryan CW, Blanke CD, Kurzrock R. A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort results. J Gynecol Oncol. 2026 Mar 25. doi: 10.3802/jgo.2026.37.e92. PMID: 41995270.
Nascimento de Lima P, Bartholomew L, May FP, Coronado GD, Rutter CM. The triple effect of colorectal cancer screening: reducing deaths, government spending, and mortality disparities. J Natl Cancer Inst. 2026 Feb 1;118(2):360-363. doi: 10.1093/jnci/djaf202. PMID: 40737504; PMCID: PMC13014358.
Coronado GD, Hoffman RM, Llavona-Ortiz J, Rutter CM. The Centers for Medicare and Medicaid Services and others misunderstand stool testing for colorectal cancer. J Natl Cancer Inst. 2026 Mar 1;118(3):386-391. doi: 10.1093/jnci/djaf341. PMID: 41324575; PMCID: PMC13017659.
Pi S, Rutter CM, Pineda-Antunez C, Chen JH, Goldhaber-Fiebert JD, Alarid-Escudero F. Discrete-Event Simulation Modeling Framework for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline. Pharmacoeconomics. 2026 Apr;44(4):409-427. doi: 10.1007/s40273-025-01571-3. PMID: 41575713; PMCID: PMC13013340.
Rutter CM, Maerzluft CE, Matrajt L, Nascimento de Lima P, Issaka RB, Marsh TL. CRC-SPIN version 3.0: an updated policy model for colorectal cancer screening that includes the serrated pathway. J Natl Cancer Inst. 2026 Feb 16:djag037. doi: 10.1093/jnci/djag037. PMID: 41697969.
Coronado GD, Rutter C, Nascimento De Lima P. Response to Piscitello et al. J Natl Cancer Inst. 2026 Mar 17:djag075. doi: 10.1093/jnci/djag075. Epub ahead of print. PMID: 41859811.
Coronado GD, Dickerson JF, Tsou MH, Shivaprakash N, Rosales AG, Voelkel JL, Whyte MA, Shuster E, Petrik AF, Llavona-Ortiz JY, Jenkins CL, Rutter CM, Escaron AL. Temporal and geographic analyses of colorectal cancer screening during and after the COVID-19 pandemic in a federally qualified health center. PLoS One. 2026 Mar 24;21(3):e0345248. doi: 10.1371/journal.pone.0345248. PMID: 41875138; PMCID: PMC13012522.
Campbell KM, Chen DG, Bustami ZE,... Wu MC, et al. Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1. Cancer Discov. 2026 Apr 21. doi: 10.1158/2159-8290.CD-25-1745. PMID: 42013417.
Tan J, Wu Y, Barve R, Lalmansingh J, Li F, Payne P, Kong N, Jin SC, Shan Y, Zhou R, Ge X, Li JJ, Head R, Sun Y. SnakeAltPromoter Facilitates Differential Alternative Promoter Analysis. Comput Struct Biotechnol J. 2026 Apr 9;35(1):0033. doi: 10.34133/csbj.0033. PMID: 41993886; PMCID: PMC13082578.
Kanwal F, Feng Z, Hoshida Y, Chhatwal J, Wong VW, Ioannou GN, Nahon P, Lotter W, Ning J, Taouli B, Marquez G, Fu SW, Singal AG. Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium. Hepatology. 2026 Apr 20. doi: 10.1097/HEP.0000000000001745. PMID: 42008824.
Gogebakan KC, Lange J, Gulati R, Dubard-Gault ME, Drescher CW, Malone KE, Etzioni R. Impact of Multicancer Screening on Late-Stage Cancer at Diagnosis in Breast Cancer Survivors: A Modeling Study. JCO Precis Oncol. 2026 May;10(5). doi: 10.1200/PO-26-00305. . PMID: 42150149.
Chen YQ, Wang Y, Zhang X, Prentice RL. Estimating attributable risk functions for censored time-to-event in disease prevention research. Lifetime Data Anal. 2026 Mar 27;32(2):24. doi: 10.1007/s10985-026-09704-2. PMID: 41888481.
Tosoian JJ, Meyers JI, Moore B, ... Zheng Y, Chinnaiyan AM. Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Prospective Multisite Validation and Comparison with MRI. J Urol. 2026 May. doi: 10.1097/JU.0000000000005095. PMID: 42048777.
Ahn J, Ahsan H, Anderson GL, ... Hsu L, et al. Design of MOSAAIC (Multi-Ethnic Observational Study in American Asian and Pacific Islander Communities). JACC Asia. 2026 Apr 16:S2772-3747(26)00168-7. doi: 10.1016/j.jacasi.2026.02.027. PMID: 41999375.
Chalitsios CV, Chan WC, Markozannes G, .... Hsu L, .... Sun W, et al. Alcohol consumption and molecular subtypes of colorectal cancer: pooled observational and Mendelian randomization analyses. Am J Clin Nutr. 2026 Apr 22:101308. doi: 10.1016/j.ajcnut.2026.101308. PMID: 42031341.
Zhao K, Pershad Y, Xue L, Vlasschaert C, Corty RW, Heimlich JB, Kooperberg C, Reiner AP, Bick AG. Clonal Hematopoiesis and Risk of Stroke: Evidence From Over 800 000 Individuals Across 3 Cohorts. Stroke. 2026 Apr. doi: 10.1161/STROKEAHA.125.054128.. PMID: 41948817; PMCID: PMC13124249.
Huang YJ, Kurniansyah N, Goodman MO,... Kooperberg C, et al.; Trans-Omics for Precision Medicine Consortium; Sofer T. Admixture-informed polygenic risk reporting using the ePRS framework. Nat Commun. 2026 Apr 30. doi: 10.1038/s41467-026-72457-x. PMID: 42062286.
Avanessian SC, van den Bijgaart RJE, Chew NW, Supper VM, Tang TT, Zhang Y, Zhao YQ, Abe K, Gauthier J, Barry KC. IL2/IL15 Signaling Induces NK Cell Production of FLT3LG, Augmenting Anti-PD-1 Immunotherapy. Cancer Immunol Res. 2026 Jan 8;14(1):122-138. doi: 10.1158/2326-6066.CIR-24-1259. PMID: 41081432; PMCID: PMC12582536.
Zhu K, Chuen Gary Chan K, Zhao YQ, Zheng Y. Two-Step Error-Controlling Classifiers With Application to Cost-Effective Disease Diagnosis. Stat Med. 2026 Apr;45(8-9):e70498. doi: 10.1002/sim.70498. PMID: 41923535.
Song X, Wang CY. A Corrected Score Approach for Proportional Hazards Model With Error-Contaminated Covariates Subject to Detection Limits. Stat Med. 2025 Oct;44(23-24):e70243. doi: 10.1002/sim.70243. PMID: 41055602; PMCID: PMC12503091.
Lee C, Song D, Chen S, Li JJ. ClusterDE: A Statistical Software Package for Removing Double-Dipping Bias in Post-Clustering Differential Expression Analysis. J Comput Biol. 2026 Jan;33(1):36-42. doi: 10.1177/15578666251383562. Epub 2026 Jan 30. PMID: 41060830.
Hemminger Z, De Ocampo H, Xie F, Zhai Z, Li JJ, Wollman R. CIPHER: An end-to-end framework for designing optimized aggregated spatial transcriptomics experiments. bioRxiv [Preprint]. 2026 Jan 21:2026.01.08.698503. doi: 10.64898/2026.01.08.698503. PMID: 41542523; PMCID: PMC12803149.
BioDIGS Consortium; Alberts T, Albritton CF, Alcazar R, . . . A, Hoffman AM, Hoffmann T, Horton AM, Hughes A, Humphries EM, Ikechi-Konkwo JS, Ishtiaq A, Jackson R, James JR, James K, Jamison SA, Jimenez A, Johnson R, Kauffman A, Kaur H, Kc K, Keeton A, Kelly OE, Kerr J, Kucher N, Kuehu DL, Larson WA, Lee J, Lee A, Leek JT, et al. Unearthing soil biodiversity through collaborative genomic research and education. Nat Genet. 2026 Jan;58(1):3-8. doi: 10.1038/s41588-025-02442-5. PMID: 41461908; PMCID: PMC12799090.
Zhang T, Hua X, Mohindroo C, . . . Kooperberg C, et al. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. J Natl Cancer Inst. 2026 Mar 1;118(3):437-447. doi: 10.1093/jnci/djaf308. PMID: 41206949; PMCID: PMC13005432.
Lee HH, Avery CL, Graff M, Kim D, Arias J, Van Horn L, Kooperberg C, North KE. Impact of Genetic Predisposition to Obesity on Long-Term Maintenance of Modest Weight Loss in Postmenopausal Women. Obesity (Silver Spring). 2026 Apr;34(4):782-786. doi: 10.1002/oby.70175. Epub 2026 Mar 6. PMID: 41792585; PMCID: PMC13032054.
Yang X, Kim MS, Zhu X, . . . , Kooperberg C, et al. An integrated germline and somatic genomic model for coronary artery disease. Nat Commun. 2026 Mar 26. doi: 10.1038/s41467-026-70379-2. Epub ahead of print. PMID: 41888514.
Sanchez Mendez J, Queme B, Fu Y, Morrison JL, . . . Hsu L, Peters U, Stern MC, Gauderman WJ. TGF-β-pathway-based polygenic risk score modifies the association between red meat intake and colorectal cancer risk: Application of a novel pathway-based PRS method. Cancer Epidemiol Biomarkers Prev. 2026 Apr 1. doi: 10.1158/1055-9965.EPI-25-1754. PMID: 41920173.
Liu P, Li JJ. mcRigor: A Statistical Software Package for Evaluating and Optimizing Metacell Partitioning in Single-Cell Data Analysis. J Comput Biol. 2026 Jan;33(1):43-47. doi: 10.1177/15578666251383561. Epub 2026 Jan 30. PMID: 41066085; PMCID: PMC12872216.
Thomas CE, Loroña NC, LaBrie SD, Curtis KR, Yin H, Ma N, Randolph TW, Qu C, Huyghe JR, Thomas S, Hsu L, et al. The phylum Fusobacteriota is associated with CRC-specific mortality: Results from the Translational Research Program in Cancer Differences across Populations. Cancer Epidemiol Biomarkers Prev. 2026 Apr 1. doi: 10.1158/1055-9965.EPI-25-1580. Epub ahead of print. PMID: 41920180.
Chari ST, Feng Z. Reply. Gastroenterology. 2026 Feb 21:S0016-5085(26)00158-7. doi: 10.1053/j.gastro.2026.02.019. Epub ahead of print. PMID: 41730389.
Gogebakan KC, Kunst N, Ghodsi A, Owens L, Iravani A, Etzioni R. Cost-Effectiveness Analysis of 177Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer from a U.S. Health Care Perspective. J Nucl Med. 2026 Mar 19:jnumed.125.271825. doi: 10.2967/jnumed.125.271825. Epub ahead of print. PMID: 41856667.
Etzioni R, Gogebakan K, Gulati R, Owens L, Lange J, Kessler L, Smith R, Schrag D, Robbins HA. Measuring and defining screening benefit in a new era of cancer early detection. J Natl Cancer Inst. 2026 Mar 30:djag100. doi: 10.1093/jnci/djag100. Epub ahead of print. PMID: 41912411.
Rillamas-Sun E, Huang Y, Langley BO, Donzella SM, Cobos S, Guthrie KA, Davidson NE, Di C, Greenlee H. Comparisons of Physical Activity and Sedentary Behavior Measurements From the ActiGraph, International Physical Activity Questionnaire, and Fitbit in Women With History of Breast Cancer. J Phys Act Health. 2025 Dec 5;23(3):425-433. doi: 10.1123/jpah.2025-0009. PMID: 41325737.
Yan Y, Chen W, Ge X, Sun J, Yu L, Garcia-Mansfield K, Zhang X, Yu Y, Xiong W, Zou D, An G, Jia Z, Pirrotte P, Li JJ, Yu Z, Hao M, Qiu L, Qi J, Wang L, Yi S. Proteogenomic features define subtypes of mantle cell lymphoma. Blood Adv. 2026 Mar 5:bloodadvances.2025018701. doi: 10.1182/bloodadvances.2025018701. Epub ahead of print. PMID: 41785305.
Dong, C.Y., Cen, Y., Song, D., and Li, J.J. (2026). scDesignPop generates realistic population-scale single-cell RNA-seq for power analysis, benchmarking, and privacy protection. bioRxiv.
Cai Y, Surapaneni A, Vasconcelos AG, Johnson M, Hsu L, Sun W, Kooperberg C, et al. Alterations of Plasma Metabolites Associated with Sickle Cell Trait. Clin J Am Soc Nephrol. 2026 Feb 27. doi: 10.2215/CJN.0000001015. Epub ahead of print. PMID: 41758580.
Booth A, Hillman S, Laumann K, Zhao YQ, LeBlanc M, et al. PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials. J Thorac Oncol. 2026 Feb 24:103650. doi: 10.1016/j.jtho.2026.103650. Epub ahead of print. PMID: 41747891.
Singal AG, Jin Q, Marrero J, Parikh ND, Lok AS, Lopez C, Page-Lester S, Roberts LR, Reddy R, Luster M, Khaderi S, Asrani SK, El-Serag HB, Kanwal F, Feng Z, Tayob N. Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis. Hepatol Commun. 2026 Feb 19;10(3):e00902. doi: 10.1097/HC9.0000000000000902. PMID: 41730232; PMCID: PMC12922931.
Hoffman AM, Cocciardi JM, Manna P, Alvarado-Serrano DF, Cavender-Bares J, Groffman PM, Hall SJ, Hobbie SE, Lerman SB, Padullés Cubino J, Pataki DE, Trammell TLE, Avolio ML. Genetic Diversity and Population Structure in Cities Is Not Consistent Among Cosmopolitan Plant Species. Mol Ecol. 2026 Feb;35(3):e70261. doi: 10.1111/mec.70261. PMID: 41641558.
Castellino SM, Li H, Herrera AF, LeBlanc M, et al. Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826. J Clin Oncol. 2026 Feb 20;44(6):449-454. doi: 10.1200/JCO-25-00203. Epub 2026 Jan 9. PMID: 41512237; PMCID: PMC13192332.
Brück CC, Mwangi LW, van Wifferen F, Hsu L, Thomas M, Peters U. Risk-based screening for early detection of colorectal cancer: an overview. Best Pract Res Clin Gastroenterol. 2026 Feb;80:102014. doi: 10.1016/j.bpg.2025.102014. Epub 2025 May 8. PMID: 41724531.
Eyrich NW, Huang Y, Zheng Y, Wei J, Sokoll L, Chan DW, Patil D, Chinnaiyan A, Tomlins SA, Lotan Y, Lin D, Scherr D, Wang Y, Kibel A, Taneja SS, Bidair M, Thompson IM, Sanda MG, Narayan VM. Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer. JU Open Plus. 2026 Feb 19;4(2):e00019. doi: 10.1097/JU9.0000000000000425. PMID: 41709952; PMCID: PMC12911490.
Tjader NP, Ramroop J, Gandhi T, Dauch C, Meadows O, Stevens P, Pearlman R, Hampel H, Aglago EK, Berndt SI, Bloomer A, Brenner H, Buchanan DD, Campbell PT, Cao Y, Chan AT, Cheng I, Dimou N, Drew DA, French AJ, Georgeson P, Giannakis M, Giles GG, Gomez M, Gruber SB, Hoffmeister M, Huang WY, Hullar MAJ, Huyghe JR, Loroña N, Moreno V, Newton CC, Nowak JA, Obón-Santacana M, Ogino S, Pellatt A, Peoples AR, Permuth JB, Schmit SL, Schoen RE, Siegel EM, Steinfelder RS, Sun W, Teer JK, Thomas CE, Trinh QM, Tsilidis K, Ugai T, Um CY, Van Guelpen B, Zaidi SH, Figueiredo J, Peters U, Phipps AI, McElroy JP, Toland AE. Association of germline variants with KRAS-mutation status in colorectal cancer. Sci Rep. 2026 Feb 13. doi: 10.1038/s41598-026-39644-8. Epub ahead of print. PMID: 41688657.
LaMonte MJ, Hyde ET, Nguyen S, Castro E, Seguin-Fowler RA, Eaton CB, Miller CR, Di C, Stefanick ML, LaCroix AZ. Muscular Strength and Mortality in Women Aged 63 to 99 Years. JAMA Netw Open. 2026 Feb 2;9(2):e2559367. doi: 10.1001/jamanetworkopen.2025.59367. PMID: 41686437; PMCID: PMC12905654.
Kanwal F, Lopez C, Ning J, Luster M, Reddy KR, Parikh ND, Singal AG, Marrero JA, Chhatwal J, Feng Z, Page-Lester S, Koay EJ, El-Serag HB. Validation of THCC-RI in the Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. Clin Gastroenterol Hepatol. 2026 Feb 9:S1542-3565(26)00070-4. doi: 10.1016/j.cgh.2026.01.041. Epub ahead of print. PMID: 41672261.
Hill CM, Malen RC, Reedy AM, Kahsai O, Curtis K, Ma N, Randolph TW, Ma J, Thomas CE, Ogino S, Potter JD, Buchanan DD, Newcomb PA, Hullar MAJ, Phipps AI. Associations of epidemiologic risk factors with Fusobacterium nucleatum and bacterial alpha diversity in the colorectal tumor-associated microbiota. Cancer Causes Control. 2026 Feb 10;37(3):45. doi: 10.1007/s10552-026-02133-4. PMID: 41665694; PMCID: PMC12891059.
Peoples AR, Obón-Santacana M, Kim AE, Kawaguchi ES, Fu Y, Qu C, Moratalla-Navarro F, Morrison J, Lin Y, Arndt V, Berndt SI, Bien SA, Bishop DT, Bouras E, Brenner H, Buchanan DD, Campbell PT, Chan AT, Chang-Claude J, Conti DV, Corley DA, Devall MA, Dimou N, Drew DA, Gruber SB, Gunter MJ, Harlid S, Harrison TA, Hoffmeister M, Hsu L, Huyghe JR, Keku TO, Kundaje A, Lewinger JP, Li L, Lynch BM, Le Marchand L, Martín V, Murphy N, Newton CC, Ogino S, Hardikar S, Ose J, Pai RK, Palmer JR, Papadimitriou N, Pardamean B, Pellatt AJ, Pinchev M, Platz EA, Potter JD, Rennert G, Ruiz-Narvaez EA, Sakoda LC, Schoen RE, Shcherbina A, Stern MC, Su YR, Thomas CE, Tian Y, Tsilidis KK, Um CY, van Duijnhoven FJB, Van Guelpen B, Visvanathan K, Wang J, White E, Wolk A, Woods MO, Wu AH, Ulrich CM, Peters U, Gauderman WJ, Moreno V. Genetic risk factors modulate the association between physical activity and colorectal cancer. BMC Med. 2026 Feb 5. doi: 10.1186/s12916-026-04675-5. Epub ahead of print. PMID: 41645200.
Xiong Y, Chan KCG, Gorfine M, Hsu L. Assessing the Benefits and Burdens of Preventive Interventions. Stat Med. 2026 Feb;45(3-5):e70410. doi: 10.1002/sim.70410. PMID: 41641624. Samorodnitsky S, Campbell K, Little A, Ling W, Zhao N, Chen YC, Wu MC. Detecting clinically relevant topological structures in multiplexed spatial proteomics using TopKAT. Patterns (N Y). 2026 Jan 9;7(1):101456. doi: 10.1016/j.patter.2025.101456. PMID: 41583981; PMCID: PMC12827733.
Montgomery B, Lynch JA, Brown J, Maxwell KN, Teerlink CC, Kabilovic N, Stoll K, Simon J, Kogan M, Hassan S, Whitbourne SB, Muralidhar S, Schoen MW, Ramoni R, Gaziano JM, Sokolova AO, Cheng HH, Etzioni R, Pritchard CC. Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study. Cancer. 2026 Feb 1;132(3):e70283. doi: 10.1002/cncr.70283. PMID: 41615269; PMCID: PMC12857595.
Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, Campbell KM, Carson WE 3rd, Wada DA, Plaza JA, In GK, Ikeguchi A, Hyngstrom J, Brohl AS, Chmielowski B, Khushalani NI, Markowitz J, Monroe M, Contreras CM, Bowles T, Norman K, Medina E, Gonzalez CR, Baselga-Carretero I, Garcilazo IP, Vega-Crespo A, Chen JM, Deen NNA, Patel SP, Grossmann KF, Sondak VK, Sharon E, Moon J, Wu MC, Ribas A. Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial. Nat Cancer. 2026 Feb;7(2):272-282. doi: 10.1038/s43018-025-01113-y. Epub 2026 Jan 29. PMID: 41611998; PMCID: PMC12948668.
Pareek E, Pershad Y, Zhao K, Uddin MM, Xue L, Vlasschaert C, Mack TM, Haessler J, Collins JM, Glick E, Glaser V, Heise R, Ling W, Haring B, Shadyab A, Beydoun H, Wallace R, Jaiswal S, Manson JE, Natarajan P, Honigberg MC, Kooperberg C, Whitsel EA, Kitzman JO, Bick AG, Reiner AR, Desai P. Metformin does not significantly alter longitudinal dynamics of clonal hematopoiesis. Clin Cancer Res. 2026 Jan 28. doi: 10.1158/1078-0432.CCR-25-3606. Epub ahead of print. PMID: 41603726.
Samorodnitsky S, Campbell K, Little A, Ling W, Zhao N, Chen YC, Wu MC. Detecting clinically relevant topological structures in multiplexed spatial proteomics using TopKAT. Patterns (N Y). 2026 Jan 9;7(1):101456. doi: 10.1016/j.patter.2025.101456. PMID: 41583981; PMCID: PMC12827733.
Chen Z, Song W, Li Q, Li C, Wen W, Huyghe JR, Law PJ, Fernandez-Rozadilla C, Timofeeva MN, Thomas M, Schmit SL, Martin V, Devall M, Dampier C, Moratalla-Navarro F, Cai Q, Wang J, Shi J, Kweon SS, Tanikawa C, Jia WH, Shu X, Long J, Gao J, Kim J, Shin A, Matsuo K, Jee SH, Jung KJ, Wang N, Kim DH, Ping J, Yang G, Shin MH, Ren Z, Oh JH, Oze I, Ahn YO, Gao YT, Pan ZZ, Kamatani Y, Van Kaer L, Wu L, Li B, Matsuda K, Shu XO, Hsu L, Dunlop MG, Gruber SB, Houlston R, Tomlinson I, Li L, Lau KS, Moreno V, Casey G, Peters U, Zheng W, Guo X. Mixed-model and transcriptome-wide association analyses identify transcription factors and genes associated with colorectal cancer susceptibility. Nat Commun. 2026 Jan 15;17(1):1377. doi: 10.1038/s41467-025-68127-z. PMID: 41540004; PMCID: PMC12877115.
Brzoska T, Kaminski TW, Katoch O, Menchikova EV, Alagbe AE, Tashbook SE, Tofovic SP, Jonassaint JC, St Croix CM, Watkins SC, Howe S, Field JJ, Seyerle AA, Pradhan-Sundd T, Laurie C, Pankratz ND, Smith NL, Goode EL, Pankow JS, Kooperberg C, Kato GJ, Zhang Y, Novelli EM, Gladwin MT, Jackson EK, Nouraie SM, Sundd P. CD39 polymorphism enables lung thrombosis in sickle cell disease. Nat Commun. 2026 Jan 14;17(1):1693. doi: 10.1038/s41467-026-68396-2. PMID: 41530145; PMCID: PMC12909804.
Johnson M, Cai Y, Vasconcelos AG, Orchard P, Auer PL, Lettre G, Wen J, Franceschini N, Kooperberg C, Sun W, Hsu L, Raffield LM, Reiner AP. Whole Blood Transcriptomic Analysis of Sickle Cell Trait. Eur J Haematol. 2026 Jan 13. doi: 10.1111/ejh.70114. Epub ahead of print. PMID: 41528117.
Liu D, Song B, Li Z, Zhang S, Fabiha T, Zhao J, Inoki A, Piccand J, Soh CL, Dixon G, Zhong A, Hu N, Luo R, Ozlusen B, Menon V, Zhou T, Qiu X, Gradwohl G, Yang D, Dey K, Sun W, Li W, Huangfu D. A stem cell knockout village reveals lineage rewiring and a non-canonical islet cell fate in monogenic diabetes. bioRxiv [Preprint]. 2025 Dec 25:2025.12.23.696311. doi: 10.64898/2025.12.23.696311. PMID: 41509490; PMCID: PMC12776134.
Werwath KE, Lawn RB, Salem MT, Li T, Mitchell BL, Shen H, Gordon SD, Kung B, Stafford C, Vemuri M, Ratanatharathorn A, Meijsen J, Shadyab AH, Kooperberg C, Koenen KC, Crandall CJ, Martin NG, Duncan LE. Trans-ancestry GWAS of hot flashes reveals potent treatment target and overlap with psychiatric disorders. Commun Med (Lond). 2026 Jan 6;6(1):51. doi: 10.1038/s43856-025-01305-8. PMID: 41495267; PMCID: PMC12830824.
Van Buren E, Zhang Y, Li X, Selvaraj MS, Li Z, Zhou H, Palmer ND, Arnett DK, Blangero J, Boerwinkle E, Cade BE, Carlson JC, Carson AP, Chen YI, Curran J, Duggirala R, Fornage M, Franceschini N, Graff M, Gu C, Guo X, He J, Heard-Cosa N, Hou L, Hung YJ, Kalyani RR, Kardia SLR, Kenny E, Kooperberg C, Kral BG, Lange L, Levy D, Li C, Liu S, Lloyd-Jones D, Loos RJF, Manichaikul AW, Martin LW, Mathias R, Minster RL, Mitchell BD, Mychaleckyj JC, Naseri T, North K, O'Connell J, Perry JA, Peyser PA, Psaty BM, Raffield LM, Vasan RS, Redline S, Reiner AP, Rich SS, Smith JA, Spitzer B, Tang H, Taylor KD, Tracy R, Viali S, Yanek L, Zhao W; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium; Rotter JI, Peloso GM, Natarajan P, Lin X. cellSTAAR: incorporating single-cell-sequencing-based functional data to boost power in rare variant association testing of noncoding regions. Nat Methods. 2026 Feb;23(2):338-349. doi: 10.1038/s41592-025-02919-5. Epub 2025 Dec 31. PMID: 41476111.
Quandt ZE, Finnigan S, Hill V, Dib JE, Burian J, Tessler S, Davidson D, Naqash AR, Anderson MS, Othus M, Sharon E. Immune Checkpoint Inhibitor-Induced Diabetes Across National Cancer Institute Trials That Included PD-1 or PD-L1 Agents. JAMA Oncol. 2026 Feb 1;12(2):194-199. doi: 10.1001/jamaoncol.2025.5594. PMID: 41452607; PMCID: PMC12743307.
Li B, Lin R, Ni T, Yan G, Burns M, Li JJ, Yao Z. CellScope: high-performance cell atlas workflow with tree-structured representation. Nat Commun. 2025 Dec 30;17(1):1130. doi: 10.1038/s41467-025-67890-3. PMID: 41469386; PMCID: PMC12855844.
Harrison TA, Zaidi SH, Yin H, Steinfelder RS, Qu C, Aglago EK, Berndt SI, Boardman LA, Brenner H, Buchanan DD, Campbell PT, Cao Y, Chan AT, Chanock SJ, Doheny KF, Drew DA, Figueiredo JC, French AJ, Gallinger S, Georgeson P, Giannakis M, Goode EL, Gruber SB, Gsur A, Gunter MJ, Harlid S, Hoffmeister M, Huang WY, Hullar MA, Huyghe JR, Jenkins MA, Lin Y, Moreno V, Murphy N, Newcomb PA, Newton CC, Nowak JA, Obón-Santacana M, Ogino S, Shelford T, Song M, Thomas CE, Toland AE, Ugai T, Um CY, Van Guelpen B, Trinh QM, Sun W, Hudson TJ, Hsu L, Peters U, Phipps AI. Genomic characterization of colorectal tumors: insights into significantly mutated genes, pathways, and survival outcomes. BMC Cancer. 2025 Dec 18;26(1):109. doi: 10.1186/s12885-025-15440-x. PMID: 41413856; PMCID: PMC12831426.
Sevilla-González M, Wang N, Hanson PA, Bebo A, Hitchcock D, Hsu S, Westerman KE, Cromer SJ, Barry VG, Borns-Weil Y, Zhang Y, Ben-Yossef O, Patel CJ, Franceschini N, Taylor KD, Ávila-Pacheco J, Clish CB, Gertzen RE, Raffield LM, Kooperberg C, Rich SS, Dupuis J, Rotter JI, Liu CT, Meigs JB, Manning AK. Dissecting Genetic and Environmental Determinants of Plasma Molecular Signatures and Their Link to Type 2 Diabetes Risk. medRxiv [Preprint]. 2025 Nov 28:2025.11.26.25341007. doi: 10.1101/2025.11.26.25341007. PMID: 41358287; PMCID: PMC12676399.
Ferrier K, Graff M, Konigsberg IR, Stanislawski M, Highland HM, Raffield LM, Carson AP, Boerwinkle E, Norris JM, Gignoux CR, Hendricks AE, Raghavan S, North KE, Young KL, Justice AE, Allison MA, Budoff MJ, Kasela S, Aguet F, Joseph JJ, Kooperberg C, Rich SS, Rotter JI, Lange EM, Lange LA. Epigenome-wide association study meta-analysis of BMI in African Americans. HGG Adv. 2026 Jan 15;7(1):100552. doi: 10.1016/j.xhgg.2025.100552. Epub 2025 Dec 4. PMID: 41351263; PMCID: PMC12903085.
Perkins RB, Wolf AMD, Church TR, Elkin EB, Skates SJ, Etzioni RD, Guerra CE, Herzig A, Hoffman RM, Oeffinger KC, Raoof S, Shih YT, Walter LC, Zeigler-Johnson C, Manassaram-Baptiste D, Smith RA. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026 Jan-Feb;76(1):e70041. doi: 10.3322/caac.70041. Erratum in: CA Cancer J Clin. 2026 Jan-Feb;76(1):e70066. doi: 10.3322/caac.70066. PMID: 41342729; PMCID: PMC12677112.
Le CM, Chen X, Kodaira S, Othus M, Gang M, Davis C, Basom RS, Cherian S, Walter RB. Immunophenotypic abnormality quantification refines multiparameter flow cytometry-based measurable residual disease testing in adults allografted for acute myeloid leukemia in morphologic remission. Hemasphere. 2026 Jan 29;10(2):e70310. doi: 10.1002/hem3.70310. PMID: 41623930; PMCID: PMC12854164.
Zhao LP, Papadopoulos GK, Skyler JS, Parikh HM, Kwok WW, Lybrand TP, Bondinas GP, Moustakas AK, Wang R, Pyo CW, Nelson WC, Geraghty DE, Lernmark Å. Profiling Associations Between IGHG-FCGR Ligand-Receptor Interactions and Disease Progression From Stage 1 and 2 to Stage 3 Type 1 Diabetes. Diabetes. 2026 Jan 20;75(2):379-388. doi: 10.2337/db25-0610. PMID: 41335420; PMCID: PMC12823336.